PUBLISHER: BCC Research | PRODUCT CODE: 1407932
PUBLISHER: BCC Research | PRODUCT CODE: 1407932
The global market for research antibodies is estimated to increase from $3.7 billion in 2023 to reach $5.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
The global market for research antibodies for ELISA is estimated to increase from $770.1 million in 2023 to reach more than $1.2 billion by 2028, at a CAGR of 10.0% from 2023 through 2028.
The global market for research antibodies for western blot is estimated to increase from $856.4 million in 2023 to reach nearly $1.2 billion by 2028, at a CAGR of 6.8% from 2023 through 2028.
This study focuses on the market side of research antibodies, as opposed to the technical side. Different market segments for this specific market are covered. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including recombinant antibodies; customer type-based market segments include universities and academic institutions, pharmaceutical and biotech companies and other types of customers (e.g., governmental research labs, contract research organizations [CROs]); geography-based market segments include North America, Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
In this report, the market for research antibodies is segmented based on product type, clonality, host species, major reactivities, applications, end-user, and geography. Based on application type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC) (i.e., types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC). Based on major reactivities, the market is segmented into anti-human, anti-rat and anti-mouse. The market is also presented based on product type, which is further segmented into primary and secondary antibodies.
The market has been geographically segmented into the North America, Europe, Asia-Pacific and Rest of the World (i.e., South America, Middle East and Africa) regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries) will be covered in the regional segment. For market estimates, data will be provided for 2022 as the base year, with estimates for 2023 and forecast value for 2028.
Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
Figure :